Kala Pharmaceuticals stock up 750% in 3 days after upbeat FDA news on PCED treatment

Shares of Kala Pharmaceuticals Inc. KALA, +60.35% have rocketed higher in for three-straight sessions, toward a more-than 8-fold gain, since the biopharmaceutical company announced positive news regar...

Kala Pharmaceuticals stock rockets nearly 300% after FDA OKs IND application for PCED treatment

Shares of Kala Pharmaceuticals Inc. KALA, +219.90% quadrupled in very volatile trading Wednesday, after the biopharmaceutical company said the Food and Drug Administration accepted its investigational...